Use of pioglitazone in people with type 2 diabetes mellitus with coronavirus disease 2019 (COVID-19): Boon or bane?-Reference-Cited by-同舟云学术

Use of pioglitazone in people with type 2 diabetes mellitus with coronavirus disease 2019 (COVID-19): Boon or bane?

Published:2020-09 Issue:5 Volume:14 Page:829-831
ISSN:1871-4021
Container-title:Diabetes & Metabolic Syndrome: Clinical Research & Reviews
language:en
Short-container-title:Diabetes & Metabolic Syndrome: Clinical Research & Reviews

Author:

Jagat J Mukherjee,Kalyan K Gangopadhyay,Subir Ray

Publisher

Elsevier BV

Subject

General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference13 articles.

1. Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target;Zhang;Intensive Care Med,2020

2. Pioglitazone upregulated angiotensin converting enzyme 2 expression in insulin-sensitive tissues in rats with high-fat diet-induced non-alcoholic steatohepatitis;Zhang;Sci World J,2014

3. Effect of angiotensin-converting enzyme inhibitor and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2;Ferrario;Circulation,2005

4. Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury;Liu;Sci China Life Sci,2020

5. Loss of angiotensin-converting enzyme 2 accelerated maladaptive left ventricular remodelling in response to myocardial infarction;Kassiri;Circ Hart Fail,2009

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Effect of Antihyperglycemic Medications on COVID-19: A Meta-analysis and Systematic Review from Observational Studies;Therapeutic Innovation & Regulatory Science;2024-04-29

2. A Critical Review on the Long-Term COVID-19 Impacts on Patients With Diabetes;The American Journal of Medicine;2024-03

3. The prognostic significance of insulin resistance in COVID-19: a review;Journal of Diabetes & Metabolic Disorders;2024-01-20

4. Antidiabetic Drug Efficacy in Reduction of Mortality during the COVID-19 Pandemic;Medicina;2023-10-11

5. Advances in Research on Type 2 Diabetes Mellitus Targets and Therapeutic Agents;International Journal of Molecular Sciences;2023-08-29